Connect with us

Headlines of The Day

HealthCare Global Enterprises Q4FY24: PAT jumps 154% to Rs 213 million

HealthCare Global Enterprises has announced Q4FY24 and FY24 results.

Consolidated PAT jumped 154% to Rs 213 million against Rs 84 million in Q4FY23.

Consolidated revenue increased 12% to Rs 4,946 million in Q4FY24 against Rs 4,417 million in Q4FY23.

Adjusted EBITDA was Rs 941 million in Q4FY24 against Rs 778 million in Q4FY23, reflecting a growth of 21 percent.

FY 24 highlights
Revenue for FY24 was Rs 19,121 million, a growth of 13% yoy.

EBITDA for FY24 was Rs 3,374 million, a growth of 11% yoy.

“We experience a deep sense of fulfillment to report a consistent benchmark-beating performance across all fronts for the quarter and the fiscal year ending FY24. Year after year, HCG has achieved sustainable cancer care outcomes comparable to premier centers in the world, thanks to our unique value-based care model and focused factory approach providing patients with the right treatment at the right time, using best-in-class talent, knowledge, technology, and infrastructure,” said Dr. B.S. Ajaikumar, Executive Chairman, HealthCare Global Enterprises Ltd.

He said that given the mounting incidence of cancer in recent years, India has prudently enhanced its cancer diagnosis and treatment processes in the guiding light of visionary crusaders like HCG. “We prioritize a deep engagement in academics and research alongside an unflinching focus on patient outcomes. In the past year, we have made significant triumphs, including the successful completion of comprehensive genomic profiling for over 1,000 cancer patients, executing complex surgeries, and launching our all-in-one mobile application, among other feats.”

“Our extensive presence in 18 regions across nine states, with one-third of our centers located in tier-II and tier-III cities, underscores our sterling commitment of providing affordable and quality cancer care for every cancer patient across India. Our ability and agility to build heartfelt relationships with patients is built on a rock-solid foundation of compassion and trust, which truly sets us apart in this crucial sector. As we get ready to lock horns with new challenges and keep pace with the evolving paradigms of tomorrow, we earnestly resolve to make a bigger difference in the lives of patients, our most valued stakeholders,” he added.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!